Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 32 n° 250

Posts Tagged ‘conferences’

Global Sports Industry Conferences

Posted by fidest press agency su lunedì, 2 dicembre 2019

Stats Perform, the revolutionary leader in sports AI and data, announced that two data and analytics experts will present at upcoming industry conferences on 29 November. Duncan Alexander, vice president of data and analytics and part of the team behind popular football Twitter channel @OptaJoe, will deliver keynote remarks at the 2019 Sport Industry Global Conference in Seoul, Republic of South Korea. Tom Worville, senior data analyst, will also present at the 2019 UK Sports Tech Conference in London Stadium.Alexander’s keynote will describe how storytelling in football has been aided and enhanced by the increased availability of data since the mid-2000s. Using social media as a tool, brands must focus on words and numbers to drive the fan experience. By creating an effective story, brands can attract new sports fans by highlighting details of the game that go beyond what the average fans knows.
Worville’s presentation titled, “Quantifying Quality – Making Decisions Across the Pitch,” will provide detailed examples of how data can deliver greater insight into the gameplay and the decision-making process during a match. The presentation will take a deeper look at some of the new data points and statistics being collected and their use across competition in global football leagues.
The Sport Industry Global Conference is hosted annually by the Ministry of Culture, Sports and Tourism and organized by the Korea Institute of Sports. This year’s theme, ‘The Importance of Data in Sport and Business’, will offer a number of discussions on relevant subjects and fuel the exchange of experience, knowledge and expertise on global sports data. The UK Sports Tech Conference brings together sports industry professionals, executives and investors to discuss the latest innovations in sports technology. Key executives from across the UK sports industry will be on-hand to discuss important developments effecting the industry right now

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Axonics® to Present at Upcoming Investor Conferences

Posted by fidest press agency su venerdì, 29 novembre 2019

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation (“SNM”) devices for the treatment of bladder and bowel dysfunction, today announced that members of the senior management team will present at the following upcoming investor conferences and will be available for meetings with institutional investors: Raymond W. Cohen, Chief Executive Officer, is scheduled for a fireside chat at the Piper Jaffray Healthcare Conference on Wednesday, December 4, at 10:30 am EST at the Lotte New York Palace in New York City.
Cohen is also scheduled for a fireside chat at the Evercore ISI HealthCONx Conference on Thursday, December 5, at 2:00 pm EST at the Four Seasons Hotel in Boston.
To access the live webcast of the fireside chats at the aforementioned conferences, please visit the Events & Presentations page of the Investor Relations section of the Company’s website at ir.axonics.com. A replay of the webcasts will be available shortly after the conclusion of the fireside chats and will be archived on the Company’s website for 90 days.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Maxar Technologies to Attend Upcoming Investor Conferences

Posted by fidest press agency su lunedì, 25 novembre 2019

Maxar Technologies (NYSE:MAXR) (TSX:MAXR), a trusted partner and innovator in Earth Intelligence and Space Infrastructure, today announced that members of senior management will present at the following investor conferences:
Bank of America Merrill Lynch 2019 Leveraged Finance Conference Boca Raton Resort and Club, A Waldorf Astoria Resort
December 4, 2019 7:50 a.m. PST / 10:50 a.m. EST
Credit Suisse 7th Annual Industrials Conference Eau Palm Beach Resort & Spa December 5, 2019 5:00 a.m. PST / 8:00 a.m. EST
Both presentations will be webcast live at http://www.maxar.com.
Maxar is a trusted partner and innovator in Earth Intelligence and Space Infrastructure. We deliver disruptive value to government and commercial customers to help them monitor, understand and navigate our changing planet; deliver global broadband communications; and explore and advance the use of space. Our unique approach combines decades of deep mission understanding and a proven commercial and defense foundation to deploy solutions and deliver insights with unrivaled speed, scale and cost effectiveness. Maxar’s 5,800 team members in 30 global locations are inspired to harness the potential of space to help our customers create a better world. Maxar trades on the New York Stock Exchange and Toronto Stock Exchange as MAXR. For more information, visit http://www.maxar.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Amkor Technology to Present at Upcoming Conferences

Posted by fidest press agency su domenica, 24 novembre 2019

Amkor Technology, Inc. (NASDAQ: AMKR), a leading provider of semiconductor packaging and test services, today announced that it will participate in the following conferences:Bank of America / Merrill Lynch 2019 Leveraged Finance Conference on Tuesday, December 3, 2019. Amkor’s presentation will occur at 8:50 am Eastern Time (5:50 am Pacific Time) at the Boca Raton Resort & Club in Boca Raton, FL.Credit Suisse 23rd Annual Technology Conference on Wednesday, December 4, 2019. Amkor’s presentation will occur at 8:45 am Mountain Time (10:45 am Eastern Time) at The Phoenician in Scottsdale, AZ. An audio-only webcast of the presentation will be made available, both live and by replay, on the Investor Relations section of Amkor’s website.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Quidel to Present at Upcoming Conferences

Posted by fidest press agency su lunedì, 18 novembre 2019

New York, New York on Wednesday, December 4, 2019 at 2:00 p.m. Eastern Time (11:00 a.m. Pacific Time) 31st Annual Piper Jaffray Healthcare Conference to be held at the Lotte New York Palace hotel in New York. Evercore ISI 2nd Annual HealthCONx Conference, to be held at the Four Seasons Boston hotel in Boston, Massachusetts on Thursday, December 5, 2019 at 1:15 p.m. Eastern Time (10:15 a.m. Pacific Time). Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will present on the specified days with question-and-answer sessions scheduled immediately following each presentation. During the presentations, the company will discuss business and financial developments and trends. The company’s statements may contain or constitute material information that has not been previously disclosed. A live webcast and audio archive of each presentation will be available via the Investor Relations section of the company’s website at http://ir.quidel.com or by clicking the links below.
Participants should allow approximately five to ten minutes prior to the presentation’s start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the company’s website for 30 days.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Hanger to Present at Upcoming Investor Conferences

Posted by fidest press agency su sabato, 16 novembre 2019

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced today that members of its management team will participate in presentations and meetings with institutional investors at the following conferences: Bank of America Merrill Lynch 2019 Leveraged Finance Conference taking place December 2-4 at the Boca Raton Resort & Club in Boca Raton, Florida, with an investor presentation scheduled for Tuesday, December 3, beginning at 7:30 a.m. Eastern time.
Citi’s 2019 Global Healthcare 1×1 Conference taking place December 11-12 at the Lotte New York Palace Hotel in New York City.
CJS Securities 20th Annual “New Ideas for the New Year” Investor Conference taking place January 8 at the Four Seasons Hotel in New York City, with an investor presentation that day to be scheduled shortly.
The conference presentations will be available via webcast on the investor relations (IR) section of the Company’s website: http://www.investor.hanger.com, in addition to a replay which will also be available on the Company IR website.
About Hanger, Inc. – Built on the legacy of James Edward Hanger, the first amputee of the American Civil War, Hanger, Inc. (NYSE: HNGR) delivers orthotic and prosthetic (O&P) patient care, and distributes O&P products and rehabilitative solutions to the broader market. Hanger’s Patient Care segment is the largest owner and operator of O&P patient care clinics with approximately 800 patient care locations nationwide. Through its Products & Services segment, Hanger distributes branded and private label O&P devices, products and components, and provides rehabilitative solutions. With over 150 years of clinical excellence and innovation, Hanger’s vision is to lead the orthotic & prosthetic markets by providing superior patient care, outcomes, services and value. For more information on Hanger, visit http://www.hanger.com.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Insulet to Present at Upcoming Investor Conferences

Posted by fidest press agency su domenica, 10 novembre 2019

The 2019 Stephens Nashville Investment Conference in Nashville, TN on Wednesday, November 13, 2019, at 10:30 a.m. (Central Time). The Piper Jaffray 31st Annual Healthcare Conference in New York City, NY on Wednesday, December 4, 2019, at 9:00 a.m. (Eastern Time). Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at two upcoming investor conferences.
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: http://www.insulet.com and http://www.myomnipod.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Medallion Financial Corp. to Attend Upcoming Investor Conferences

Posted by fidest press agency su giovedì, 7 novembre 2019

Medallion Financial Corp. (Nasdaq: MFIN, “Medallion Financial” or the “Company”) announced today that the Company will attend the following upcoming investor conferences:
On Thursday, November 14, 2019, the Company will be holding one-on-one meetings at the Sandler O’Neill East Coast Financial Services Conference at The Ritz-Carlton in Naples, Florida. For those interested in having a meeting with Medallion Financial, please contact your Sandler O’Neill representative.
On Thursday, December 12, 2019, the Company will be holding one-on-one meetings at the Jefferies’ Crossover Consumer Finance Summit at The New York Palace in New York City. For those interested in having a meeting with Medallion Financial, please contact your Jefferies representative.
If there is an interest to have a meeting with management outside of the conferences, please contact the Company’s Investor Relations Department.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Voyager to Present at Upcoming Vegas Blockchain Week Conferences in October

Posted by fidest press agency su lunedì, 28 ottobre 2019

Digital (Canada) Ltd. (“Voyager” or the “Company”) (CSE: VYGR) (OTC Pink: VYGVF) (FRA: UCD2), an industry-leading best execution crypto asset broker, today announced that the Company’s management will be participating in Vegas Blockchain Week’s upcoming events:Crypto IQ Trading Event with Charlie Shrem, to be held at the Cosmopolitan of Las Vegas, NV on Monday, October 28, 2019. Mr. Ehrlich will be hosting a keynote presentation titled “Evolving the Crypto Trading Landscape” from 3:45pm PT – 4:15pm PT in the Gracia Ballroom.
World Crypto Con, to be held at the Cosmopolitan of Las Vegas, NV on Tuesday, October 29 – Thursday, October 31, 2019. Mr. Ehrlich will be participating on a panel titled “Trading Crypto Assets” from 11:20am PT – 11:40am PT in the Castellana Ballroom. Mr. Ehrlich will be speaking alongside other industry leaders including Rob Catalanello, President and CEO of B2C2, and Jeff Dorman, CIO of Arca.
Voyager Digital (Canada) Ltd. is a crypto-asset broker that provides retail and institutional investors with a turnkey solution to trade crypto assets. Voyager offers customers best execution and safe custody on a wide choice of popular crypto-assets. Voyager was founded by established Wall Street and Silicon Valley entrepreneurs who teamed to bring a better, more transparent and cost-efficient alternative for trading crypto-assets to the marketplace. Please visit us at https://www.investvoyager.com for more information and to review the latest Corporate Presentation.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Zendesk to Present at Upcoming Investor Conferences

Posted by fidest press agency su lunedì, 5 agosto 2019

Marc Cabi, Vice President of Strategy and Head of Investor Relations, will present at the Oppenheimer 22nd Annual Technology, Internet & Communications Conference in Boston, Massachusetts on Tuesday, August 6, 2019. Zendesk’s presentation is scheduled for 1:05 p.m., Eastern Time. Marc Cabi, Vice President of Strategy and Head of Investor Relations, will present at the Canaccord Genuity Growth Conference in Boston, Massachusetts on Wednesday, August 7, 2019. Zendesk’s presentation is scheduled for 8:30 a.m., Eastern Time.
Shawna Wolverton, Senior Vice President, Product, will present at the KeyBanc Technology Investor Conference in Vail, Colorado on Tuesday, August 13, 2019. Zendesk’s presentation is scheduled for 1:00 p.m., Mountain Time.
A live webcast of each presentation will be accessible by visiting Zendesk’s investor website at investor.zendesk.com. An archived version will be available for six months.
The best customer experiences are built with Zendesk. Our customer service and engagement products are powerful and flexible, and scale to meet the needs of any business. Zendesk serves businesses across a multitude of industries, with more than 145,000 paid customer accounts offering service and support in over 30 languages. Zendesk is headquartered in San Francisco, and operates worldwide with 17 offices in North America, Europe, Asia, Australia, and South America. Learn more at http://www.zendesk.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Citrix Executives to Present at Upcoming Investor Conferences

Posted by fidest press agency su lunedì, 5 agosto 2019

Citrix Systems, Inc. (NASDAQ:CTXS) today announced that executives will attend two upcoming investor conferences.Jessica Soisson, interim chief financial officer, will present at the Oppenheimer Technology, Internet and Communications Conference in Boston on August 6 at 9:05 a.m. Eastern.PJ Hough, executive vice president and chief product officer, will present at the Citi 2019 Global Technology Conference in New York on September 5 at 3:40 p.m. Eastern.
A webcast of each presentation will be available live on the investor section of the Citrix website at http://www.investors.citrix.com. A replay will be available for approximately 30 days.Citrix (NASDAQ:CTXS) is powering a better way to work with unified workspace, networking, and analytics solutions that help organizations unlock innovation, engage customers, and boost productivity, without sacrificing security. With Citrix, users get a seamless work experience and IT has a unified platform to secure, manage, and monitor diverse technologies in complex cloud environments. Citrix solutions are in use by more than 400,000 organizations including 99 percent of the Fortune 100 and 98 percent of the Fortune 500. Learn more at http://www.citrix.com.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

Arcus Biosciences to Present at Upcoming Investor Conferences

Posted by fidest press agency su mercoledì, 31 luglio 2019

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, today announced that members of the management team will participate in the following upcoming investor conferences:
BTIG Biotechnology Conference on Monday, August 12, 2019, at 12:00 pm Eastern Time in New York. Juan Jaen, Ph.D., President, will participate in a panel discussion entitled, “Solid Tumors Beyond PD-1 Monotherapy.”
2019 Wedbush PacGrow Healthcare Conference on Tuesday, August 13, 2019, at 8:35 am Eastern Time in New York. Juan Jaen, Ph.D., President, and Rekha Hemrajani, Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat. To access the live audio webcast of the fireside chat, please visit the “Investors” section of the Arcus website at http://www.arcusbio.com. A replay of the webcast will be available for 30 days following the live event.
Arcus Biosciences is a clinical-stage biopharmaceutical company focused on creating innovative cancer therapies. Arcus has several programs targeting important oncology/immuno-oncology pathways, including a dual adenosine receptor antagonist, AB928, which is in a Phase 1/1b program to evaluate AB928 in combination with other agents in multiple tumor types, and an anti-PD-1 antibody, AB122, which is being evaluated in a Phase 1 trial and is being tested in combination with Arcus’s other product candidates. Arcus’s other programs include AB154, an anti-TIGIT antibody, which is being evaluated in a Phase 1 trial as monotherapy and in combination with AB122, and AB680, a small-molecule inhibitor of CD73, which is in a Phase 1 trial. Arcus has extensive in-house expertise in medicinal chemistry, oncology, immunology, biochemistry, pharmacology and structural biology. Utilizing these unique capabilities, Arcus has developed a robust and active early-stage discovery effort focused on small-molecule pipeline expansion. For more information about Arcus Biosciences, please visit http://www.arcusbio.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Cirrus Logic to Present at Upcoming Conferences

Posted by fidest press agency su domenica, 21 luglio 2019

Boston, Aug. 6 – Cirrus Logic Chief Financial Officer Thurman Case and Vice President of Mixed-Signal Products Carl Alberty will present at the Oppenheimer Technology, Internet & Communications Conference at 10:25 a.m. EDT at the Four Seasons Hotel.
Vail, Colo., Aug. 12 – Cirrus Logic Chief Financial Officer Thurman Case and Vice President of Mixed-Signal Products Carl Alberty will present at the KeyBanc Capital Markets Annual Technology Leadership Forum at 2 p.m. MDT at the Hotel Talisa.
A live webcast of the presentations will be available on the company’s investor relations website, and an archived replay of the webcasts will be available on the website following the events.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Five Prime Therapeutics to Present at Two Upcoming Healthcare Conferences

Posted by fidest press agency su martedì, 11 giugno 2019

Montreal Wednesday, June 19th at 1:15pm ET / 10:15am PT. The 2019 Bank of Montreal Prescriptions for Success Healthcare Conference on Tuesday, June 25th at 3:00pm ET / 12:00pm PT. Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics announced that Aron Knickerbocker, Chief Executive Officer, is scheduled to present at the two investor conferences.
The presentations will be webcast and may be accessed at the “Events & Presentations” section of the Company’s website at: http://investor.fiveprime.com/events.cfm. Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.
Five Prime Therapeutics, Inc. discovers and develops innovative protein therapeutics to improve the lives of patients with serious diseases. Five Prime’s product candidates have innovative mechanisms of action and address patient populations in need of better therapies. The company focuses on researching and developing immuno-oncology and targeted cancer therapies paired with companion diagnostics to identify patients who are most likely to benefit from treatment with Five Prime’s product candidates. Five Prime has entered into strategic collaborations with leading global pharmaceutical companies and has promising product candidates in clinical and preclinical development. For more information, please visit http://www.fiveprime.com or follow us on LinkedIn, Twitter and Facebook.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

Jefferies Global Healthcare Conference

Posted by fidest press agency su venerdì, 31 maggio 2019

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced that Steve Hoerter, President and Chief Executive Officer, will present at the Jefferies Global Healthcare Conference on Thursday, June 6 at 1:30 PM ET in New York City.
A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investors.deciphera.com/news-events/events-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the rate and/or durability of response to existing cancer therapies. Our small molecule drug candidates are directed against an important family of enzymes called kinases, known to be directly involved in the growth and spread of many cancers. We use our deep understanding of kinase biology together with a proprietary chemistry library to purposefully design compounds that maintain kinases in a “switched off” or inactivated conformation. These investigational therapies comprise tumor-targeted agents designed to address therapeutic resistance causing mutations and immuno-targeted agents designed to control the activation of immunokinases that suppress critical immune system regulators, such as macrophages. We have used our platform to develop a diverse pipeline of tumor-targeted and immuno-targeted drug candidates designed to improve outcomes for patients with cancer by improving the quality, rate and/or durability of their responses to treatment.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Mastercard to Participate in Upcoming Investor Conferences

Posted by fidest press agency su giovedì, 23 maggio 2019

Mastercard Incorporated (NYSE: MA) today announced its participation in the following investor conferences in the month of June:
On Wednesday, June 5, Sachin Mehra, chief financial officer, will present at the William Blair Growth Stock Conference in Chicago. The discussion will begin at 9:00 a.m. Eastern Time and last for approximately 30 minutes.
On Tuesday, June 11, Linda Kirkpatrick, executive vice president, Merchants & Acceptance, will present at the Morgan Stanley Financials Conference in New York City. The discussion will begin at 3:15 p.m. Eastern Time and last for approximately 40 minutes.There will be a live audio webcast of each discussion and replays will be archived for 30 days at http://www.mastercard.com/investor.
Mastercard (NYSE: MA), http://www.mastercard.com, is a technology company in the global payments industry. Our global payments processing network connects consumers, financial institutions, merchants, governments and businesses in more than 210 countries and territories. Mastercard products and solutions make everyday commerce activities – such as shopping, traveling, running a business and managing finances – easier, more secure and more efficient for everyone.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

KalVista Pharmaceuticals to Present Data at Upcoming Scientific Conferences

Posted by fidest press agency su mercoledì, 22 maggio 2019

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, announced that data has been accepted for presentation at both the C1 Inhibitor Deficiency and Angioedema Workshop in Budapest, Hungary and European Academy of Allergy and Clinical Immunology (EAACI) Congress in Lisbon, Portugal.“We are excited to present more Phase 1 data on KVD900, our oral plasma kallikrein inhibitor in development for on-demand treatment of hereditary angioedema, or HAE,” said Andrew Crockett, Chief Executive Officer of KalVista. “Our Phase 2 clinical trial of KVD900 is still expected to have data late this year. We remain committed to providing options for patients to manage their disease with oral medicines.”

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Avalara to Present at Upcoming Investor Conferences

Posted by fidest press agency su venerdì, 10 maggio 2019

Avalara, Inc. (NYSE:AVLR), a leading provider of tax compliance automation for businesses of all sizes, today announced the following upcoming investor conference presentations.
Co-Founder and Chief Executive Officer Scott McFarlane will present at the J.P. Morgan 47th Annual Global Technology, Media and Communications Conference in Boston on Thursday, May 16, 2019, at 10:40 a.m. ET (7:40 a.m. PT).
Chief Financial Officer Bill Ingram will present at the Needham Emerging Technology Conference in New York on Tuesday, May 21, 2019, at 1:50 p.m. ET (10:50 a.m. PT).
Live webcasts of the presentations will be available on the Avalara investor relations website at investor.avalara.com. Archived replays will be made available for a limited time at the same location following the presentations.
Avalara helps businesses of all sizes get tax compliance right. In partnership with leading ERP, accounting, ecommerce, and other financial management system providers, Avalara delivers cloud-based compliance solutions for various transaction taxes, including sales and use, VAT, GST, excise, communications, lodging, and other indirect tax types. Headquartered in Seattle, Avalara has offices across the U.S. and around the world in Canada, the U.K., Belgium, Brazil, and India. More information at http://www.avalara.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

New Relic to Present at Upcoming Investor Conferences

Posted by fidest press agency su giovedì, 9 maggio 2019

New Relic, Inc. (NYSE: NEWR), provider of real-time insights for software-driven businesses, today announced that members of its management team will present at the following investor conferences: J.P. Morgan 47th Annual Global Technology, Media and Communications Conference in Boston on Thursday, May 16, 2019, at 8:40 a.m. ET.
Needham Emerging Technology Conference in New York on Wednesday, May 22, 2019, at 8:20 a.m. ET. Baird Global Consumer, Technology & Services Conference in New York on Thursday, June 6, 2019, at 12:50 p.m. ET.
Live webcasts of the presentations will be accessible from the investor relations page of the New Relic website at http://ir.newrelic.com. Following the events, replays will be made available at the same location.
New Relic provides the real-time insights that software-driven businesses need to innovate faster. New Relic’s cloud platform makes every aspect of modern software and infrastructure observable, so companies can find and fix problems faster, build high-performing DevOps teams, and speed up transformation projects. Learn why more than 50% of the Fortune 100 trust New Relic at newrelic.com.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

DBV Technologies to Attend Upcoming Investor Conferences

Posted by fidest press agency su sabato, 4 maggio 2019

Montrouge, France DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that members of its management team will present at the following investor conferences in May 2019:
Daniel Tassé, Chief Executive Officer, and Kevin Trapp, Chief Commercial Officer, will present at the Bank of America Merrill Lynch 2019 Health Care Conference in Las Vegas, NV, on Tuesday, May 14, 2019, at 11:20am PT.Kevin Trapp, Chief Commercial Officer, will present at the Barclays West Coast Biopharma Conference in Calistoga, CA, on Thursday, May 30, 2019, at 10:30am PT.A live webcast of the presentation at the Bank of America Merrill Lynch 2019 Health Care Conference will be available on the Investors & Media section of the Company’s website: https://www.dbv-technologies.com/investor-relations/. A replay of the presentation will also be available on DBV’s website within one hour after the event.
DBV Technologies is developing Viaskin®, a proprietary technology platform with broad potential applications in immunotherapy. Viaskin is based on epicutaneous immunotherapy, or EPIT®, DBV’s method of delivering biologically active compounds to the immune system through intact skin. With this new class of self-administered and non-invasive product candidates, the Company is dedicated to safely transforming the care of food allergic patients, for whom there are no approved treatments. DBV’s food allergies programs include ongoing clinical trials of Viaskin Peanut and Viaskin Milk, and preclinical development of Viaskin Egg. DBV is also pursuing a human proof-of-concept clinical study of Viaskin Milk for the treatment of Eosinophilic Esophagitis, and exploring potential applications of its platform in vaccines and other immune diseases. DBV Technologies has global headquarters in Montrouge, France and New York, NY. The Company’s ordinary shares are traded on segment B of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345), part of the SBF120 index, and the Company’s ADSs (each representing one-half of one ordinary share) are traded on the Nasdaq Global Select Market (Ticker: DBVT).

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »